Reports Q4 revenue $0 vs. $100K last year. As of December 31, 2025, Inhibrx (INBX) had cash and cash equivalents of $124.2M.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INBX: